Kancera AB (publ)

Kancera AB (publ)verified

KAN.ST

Price:

$0.2975

Market Cap:

$36.05M

Kancera AB (Publ) develops drugs for inflammatory diseases and cancer in Sweden and internationally. The company is developing small molecule drug candidates KAND567, which is in phase IIa clinical trial for inflammatory heart disease following infarction, as well as KAND145, which is in phase I study in healthy subjects to document desired dose levels against cancer; and Phase IIa study for the treatment of ovarian cancer. It also develops HDAC for the treatment of nerve inflammation and pain; and ROR1 inhibitors for the treatment of solid tumors and blood cancers. Kancera AB (Publ) was founded in 2010 and is based in Solna, Sweden.

Industry

Biotechnology

IPO Date

2011-02-25

Stock Exchange

STO

Ticker

KAN.ST

The Enterprise Value as of December 2025 (TTM) for Kancera AB (publ) (KAN.ST) is 8.45M

According to Kancera AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 8.45M. This represents a change of -93.90% compared to the average of 138.55M of the last 4 quarters.

Kancera AB (publ) (KAN.ST) Historical Enterprise Value (quarterly & annually)

How has KAN.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Kancera AB (publ) over the last ten years is 281.23M. The current 8.45M Enterprise Value has changed 200.64% with respect to the historical average. Over the past ten years (40 quarters), KAN.ST's Enterprise Value was at its highest in in the September 2020 quarter at 1.55B. The Enterprise Value was at its lowest in in the December 2022 quarter at 44.83M.

Quarterly (TTM)
Annual

Average

281.23M

Median

299.70M

Minimum

31.66M

Maximum

654.89M

Kancera AB (publ) (KAN.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kancera AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 893.61%

Maximum Annual Enterprise Value = 654.89M

Minimum Annual Increase = -89.60%

Minimum Annual Enterprise Value = 31.66M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202479.35M-74.77%
2023314.55M893.61%
202231.66M-89.60%
2021304.39M-53.52%
2020654.89M460.42%
2019116.86M-31.29%
2018170.08M-42.35%
2017295.01M-13.44%
2016340.82M-32.47%
2015504.72M-8.08%

Kancera AB (publ) (KAN.ST) Average Enterprise Value

How has KAN.ST Enterprise Value performed in the past?

The current Enterprise Value of Kancera AB (publ) (KAN.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

141.85M

5-year avg

276.97M

10-year avg

281.23M

Kancera AB (publ) (KAN.ST) Enterprise Value vs. Peers

How is KAN.ST’s Enterprise Value compared to its peers?

Kancera AB (publ)’s Enterprise Value is less than RLS Global AB (publ) (15.17M), greater than CombiGene AB (publ) (-24839036.00), less than NeoDynamics AB (publ) (27.05M), less than Emplicure AB (publ) (33.32M), less than FRISQ Holding AB (publ) (128.48M), less than Amniotics AB (publ) (9.13M), less than Diagonal Bio AB (publ) (17.46M), greater than Pharmiva AB (publ) (-1197289.00), greater than Idogen AB (publ) (7.48M), less than Coala-Life Group AB (publ) (9.48M),

Build a custom stock screener for Kancera AB (publ) (KAN.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kancera AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kancera AB (publ) (KAN.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kancera AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Kancera AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Kancera AB (publ) (KAN.ST)?

What is the 3-year average Enterprise Value for Kancera AB (publ) (KAN.ST)?

What is the 5-year average Enterprise Value for Kancera AB (publ) (KAN.ST)?

How does the current Enterprise Value for Kancera AB (publ) (KAN.ST) compare to its historical average?